Use of non-steroidal anti-inflammatory drugs (NSAIDs) such as celecoxib and diclofenac is associated with an increased risk of stroke, according to research published in the latest Medical Journal of Australia.

Ita Buttrose, National President of Alzheimer's Australia, has heralded an Australian-developed, world-first app as the latest digital tool in the global fight against Alzheimer's disease and other forms of dementia.

New research shows people with dementia who have a stroke are more likely to become disabled and not return home compared to people who didn't have dementia at the time they had a stroke. The study is published in the November 1, 2011, issue of Neurology®, the medical journal of the American Academy of Neurology.

The US Food and Drug Administration has approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.

On 21 October, the US Food and Drug Administration (FDA) approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. As Onfi is intended to treat a disease or condition that affects fewer than 200,000 people in the United States, it was granted orphan drug designation by the ...

The Clinical Trials Division of the McCusker Alzheimer's Research Foundation is conducting a world-first trial of an experimental drug to treat the early stages of Alzheimer's disease.

Human breastmilk has the potential to help people suffering from diseases including Parkinson's disease and diabetes, according to a researcher at The University of Western Australia.

A University of Sydney PhD student has discovered the different diets and lifestyles of South Asians compared to Europeans could lead to the two groups requiring very different doses of medicines commonly used to treat illnesses such as depression and psychosis.

A study carried out by the Primary Care Research Group at the Peninsula College of Medicine and Dentistry, supported by the National Institute for Health Research (NIHR) and NIHR PenCLAHRC, has analysed the results of an exercise programme to prevent falls in those with Parkinson's disease.

Older patients who happened to have been taking cholesterol-lowering statin drugs when admitted to the hospital with serious head injuries were 76 percent more likely to survive than those not taking the drugs, according to results of a Johns Hopkins study.